Cargando…

Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development

Certain cognitive deficits in schizophrenia, such as impaired working memory, are thought to reflect alterations in the neural circuitry of the dorsolateral prefrontal cortex (DLPFC). Gamma oscillations in the DLPFC appear to be a neural corollary of working memory function, and the power of these o...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoonover, Kirsten E., Dienel, Samuel J., Lewis, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351254/
https://www.ncbi.nlm.nih.gov/pubmed/32656540
http://dx.doi.org/10.1016/j.bionps.2020.100015
_version_ 1783557414839123968
author Schoonover, Kirsten E.
Dienel, Samuel J.
Lewis, David A.
author_facet Schoonover, Kirsten E.
Dienel, Samuel J.
Lewis, David A.
author_sort Schoonover, Kirsten E.
collection PubMed
description Certain cognitive deficits in schizophrenia, such as impaired working memory, are thought to reflect alterations in the neural circuitry of the dorsolateral prefrontal cortex (DLPFC). Gamma oscillations in the DLPFC appear to be a neural corollary of working memory function, and the power of these oscillations during working memory tasks is lower in individuals with schizophrenia. Thus, gamma oscillations represent a potentially useful biomarker to index dysfunction in the DLPFC circuitry responsible for working memory in schizophrenia. Postmortem studies, by identifying the cellular basis of DLPFC dysfunction, can help inform the utility of biomarker measures obtained in vivo. Given that gamma oscillations reflect network activity of excitatory pyramidal neurons and inhibitory GABA neurons, we review postmortem findings of alterations to both cell types in the DLPFC and discuss how these findings might inform future biomarker development and use.
format Online
Article
Text
id pubmed-7351254
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-73512542021-12-01 Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development Schoonover, Kirsten E. Dienel, Samuel J. Lewis, David A. Biomark Neuropsychiatry Article Certain cognitive deficits in schizophrenia, such as impaired working memory, are thought to reflect alterations in the neural circuitry of the dorsolateral prefrontal cortex (DLPFC). Gamma oscillations in the DLPFC appear to be a neural corollary of working memory function, and the power of these oscillations during working memory tasks is lower in individuals with schizophrenia. Thus, gamma oscillations represent a potentially useful biomarker to index dysfunction in the DLPFC circuitry responsible for working memory in schizophrenia. Postmortem studies, by identifying the cellular basis of DLPFC dysfunction, can help inform the utility of biomarker measures obtained in vivo. Given that gamma oscillations reflect network activity of excitatory pyramidal neurons and inhibitory GABA neurons, we review postmortem findings of alterations to both cell types in the DLPFC and discuss how these findings might inform future biomarker development and use. 2020-05-18 2020-12 /pmc/articles/PMC7351254/ /pubmed/32656540 http://dx.doi.org/10.1016/j.bionps.2020.100015 Text en This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Article
Schoonover, Kirsten E.
Dienel, Samuel J.
Lewis, David A.
Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development
title Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development
title_full Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development
title_fullStr Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development
title_full_unstemmed Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development
title_short Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development
title_sort prefrontal cortical alterations of glutamate and gaba neurotransmission in schizophrenia: insights for rational biomarker development
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351254/
https://www.ncbi.nlm.nih.gov/pubmed/32656540
http://dx.doi.org/10.1016/j.bionps.2020.100015
work_keys_str_mv AT schoonoverkirstene prefrontalcorticalalterationsofglutamateandgabaneurotransmissioninschizophreniainsightsforrationalbiomarkerdevelopment
AT dienelsamuelj prefrontalcorticalalterationsofglutamateandgabaneurotransmissioninschizophreniainsightsforrationalbiomarkerdevelopment
AT lewisdavida prefrontalcorticalalterationsofglutamateandgabaneurotransmissioninschizophreniainsightsforrationalbiomarkerdevelopment